Global Tobacco LLC – FDA Warning Letter, Mar 1, 2026

On March 31, 2026, the U.S. Food and Drug Administration (FDA) issued a warning letter to Dallas-based Global Tobacco, LLC, following a review of the company’s records. The investigation determined that the firm is importing and distributing nicotine pouch products in the United States, specifically "RUSH Mango Freeze 12MG," without the necessary federal authorization. Under the Federal Food, Drug, and Cosmetic (FD&C) Act, any tobacco or nicotine product introduced to the market after February 15, 2007, is classified as a "new tobacco product." To be sold legally, these products must undergo a premarket review and receive a formal marketing order from the FDA. The regulatory framework was further strengthened by 2022 legislation which clarifies that the FDA has jurisdiction over nicotine from any source, including synthetic nicotine. Because Global Tobacco, LLC, lacks the required marketing orders, the sale of these products is considered a violation of federal law. The FDA has mandated that the company submit a written response within 15 working days. This response must outline the specific actions taken to correct the violations, provide the dates when the sale and distribution of the unauthorized products were discontinued, and describe a plan for ensuring future compliance. Failure to address these issues may result in severe regulatory consequences, such as civil fines, product seizures, court-ordered injunctions, or the rejection of imported goods at the border.